Literature DB >> 29032053

Effects of combination of change in visceral fat and thigh muscle mass on the development of type 2 diabetes.

Seung Jin Han1, Soo-Kyung Kim2, Wilfred Y Fujimoto3, Steven E Kahn4, Donna L Leonetti5, Edward J Boyko6.   

Abstract

AIM: We investigated the association between combined changes of visceral fat and thigh muscle over 5 years and incident type 2 diabetes in a prospective study of Japanese Americans.
METHODS: We followed 420 nondiabetic Japanese American subjects for 5 years and assessed visceral fat and thigh muscle by computed tomography (CT) at baseline and at 5 years. We categorized study subjects into 4 body composition change groups: visceral fat loss/thigh muscle gain (VF-loss/TM-gain), visceral fat loss/thigh muscle loss (VF-loss/TM-loss), visceral fat gain/thigh muscle gain (VF-gain/TM-gain), and visceral fat gain/thigh muscle loss (VF-gain/TM-loss) by combining changes from baseline in CT measured visceral fat and estimated thigh muscle areas. We fit a logistic regression model to examine the association between body composition categories and the development of incident type 2 diabetes at 5 years.
RESULTS: Cumulative incidence of type 2 diabetes was 9.8% at 5 years. VF-gain/TM-gain and VF-loss/TM-loss groups had higher risk for incident type 2 diabetes in a model adjusted for age, sex, family history of diabetes, and body mass index compared to VF-loss/TM-gain group as the reference category (OR=6.83 (1.85-25.17), 4.55 (1.06-19.48), respectively). However, the VF-gain/TM-loss group did not show a significant association with the odds of incident diabetes (3.24; 95% CI. 0.78-13.47).
CONCLUSIONS: Concordant gain or loss in visceral fat and thigh muscle was related to higher risk of incident type 2 diabetes compared to the reference combination of loss of visceral fat and gain of thigh muscle in Japanese Americans. Published by Elsevier B.V.

Entities:  

Keywords:  Body composition; Diabetes mellitus; Epidemiology; Observational study; Skeletal muscle; Visceral adipose tissue

Mesh:

Year:  2017        PMID: 29032053      PMCID: PMC5723555          DOI: 10.1016/j.diabres.2017.10.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  35 in total

1.  Aging of skeletal muscle: a 12-yr longitudinal study.

Authors:  W R Frontera; V A Hughes; R A Fielding; M A Fiatarone; W J Evans; R Roubenoff
Journal:  J Appl Physiol (1985)       Date:  2000-04

2.  Subcutaneous thigh fat area is unrelated to risk of type 2 diabetes in a prospective study of Japanese Americans.

Authors:  D Hoyer; E J Boyko; M J McNeely; D L Leonetti; S E Kahn; W Y Fujimoto
Journal:  Diabetologia       Date:  2011-08-12       Impact factor: 10.122

3.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.

Authors: 
Journal:  Diabetes Care       Date:  1997-07       Impact factor: 19.112

Review 4.  Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases.

Authors:  Rita Rastogi Kalyani; Mark Corriere; Luigi Ferrucci
Journal:  Lancet Diabetes Endocrinol       Date:  2014-03-06       Impact factor: 32.069

5.  Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

Authors:  E J Boyko; W Y Fujimoto; D L Leonetti; L Newell-Morris
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

Review 6.  Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies.

Authors:  Lando L J Koppes; Jacqueline M Dekker; Henk F J Hendriks; Lex M Bouter; Robert J Heine
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

7.  Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study.

Authors:  Marieke B Snijder; Jacqueline M Dekker; Marjolein Visser; Lex M Bouter; Coen D A Stehouwer; Piet J Kostense; John S Yudkin; Robert J Heine; Giel Nijpels; Jacob C Seidell
Journal:  Am J Clin Nutr       Date:  2003-05       Impact factor: 7.045

8.  Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance.

Authors:  W Y Fujimoto; D L Leonetti; J L Kinyoun; W P Shuman; W C Stolov; P W Wahl
Journal:  Diabetes       Date:  1987-06       Impact factor: 9.461

9.  The association of insulin resistance and carotid atherosclerosis with thigh and calf circumference in patients with type 2 diabetes.

Authors:  Jong Suk Park; Min Ho Cho; Chul Woo Ahn; Kyung Rae Kim; Kap Bum Huh
Journal:  Cardiovasc Diabetol       Date:  2012-06-08       Impact factor: 9.951

10.  Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus.

Authors:  Ralph A Defronzo
Journal:  Diabetes       Date:  2009-04       Impact factor: 9.461

View more
  3 in total

1.  Metabolic Age, an Index Based on Basal Metabolic Rate, Can Predict Individuals That are High Risk of Developing Metabolic Syndrome.

Authors:  Sarahi Vásquez-Alvarez; Sergio K Bustamante-Villagomez; Gabriela Vazquez-Marroquin; Leonardo M Porchia; Ricardo Pérez-Fuentes; Enrique Torres-Rasgado; Oscar Herrera-Fomperosa; Ivette Montes-Arana; M Elba Gonzalez-Mejia
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-03-05

2.  Comparisons of different indices of low muscle mass in relationship with cardiometabolic disorder.

Authors:  Ju Young Kim; Sohee Oh; Hwa Yeon Park; Ji Hye Jun; Hwa Jung Kim
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Effects of Exercise Intervention on Type 2 Diabetes Patients With Abdominal Obesity and Low Thigh Circumference (EXTEND): Study Protocol for a Randomized Controlled Trial.

Authors:  Dan Liu; Ying Zhang; Liang Wu; Jingyi Guo; Xiangtian Yu; Huasheng Yao; Rui Han; Tianshu Ma; Yuchan Zheng; Qiongmei Gao; Qichen Fang; Yan Zhao; Yanan Zhao; Biao Sun; Weiping Jia; Huating Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.